Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus.

David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1670, USA.
Arthritis care & research 02/2010; 62(2):258-65. DOI: 10.1002/acr.20076
Source: PubMed

ABSTRACT To investigate the association between physical activity, functional activity of high-density lipoprotein (HDL), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (SLE).
A total of 242 SLE patients (all women) participated in this cross-sectional study from February 2004 to February 2008. Carotid plaque and intima-media thickness (IMT), antioxidant function of HDL, and traditional cardiac risk factors were measured. Physical activity was assessed from self-reports by calculating the metabolic equivalents (METS) per week and by the physical function domain of the Medical Outcomes Study Short Form 36 (SF-36). Data were analyzed using bivariate and multivariate regression analyses.
Number of METS per week spent performing strenuous exercise was negatively correlated with IMT (r = -0.4, P = 0.002) and number of plaques (r = -0.30, P = 0.0001). Physical function as assessed by the SF-36 was also negatively correlated with IMT (r = -0.14, P = 0.03) and number of plaques (r = -0.14, P = 0.04). In multivariate analyses, number of strenuous exercise METS was significantly associated with IMT (t = -2.2, P = 0.028) and number of plaques (t = -2.5, P = 0.014) when controlling for markers of SLE disease activity and damage, but not after controlling for traditional cardiac risk factors. Low physical activity, defined as <225 total METS per week, was associated with the presence of proinflammatory HDL (P = 0.03).
Low physical activity is associated with increased subclinical atherosclerosis and proinflammatory HDL in patients with SLE. Increased strenuous exercise may reduce the risk of atherosclerosis in SLE.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Current cell-based assays for determining the functional properties of high-density lipoproteins (HDL) have limitations. We report here the development of a new, robust fluorometric cell-free biochemical assay that measures HDL lipid peroxidation (HDLox) based on the oxidation of the fluorochrome Amplex Red. HDLox correlated with previously validated cell-based (r = 0.47, p<0.001) and cell-free assays (r = 0.46, p<0.001). HDLox distinguished dysfunctional HDL in established animal models of atherosclerosis and Human Immunodeficiency Virus (HIV) patients. Using an immunoaffinity method for capturing HDL, we demonstrate the utility of this novel assay for measuring HDLox in a high throughput format. Furthermore, HDLox correlated significantly with measures of cardiovascular diseases including carotid intima media thickness (r = 0.35, p<0.01) and subendocardial viability ratio (r = -0.21, p = 0.05) and physiological parameters such as metabolic and anthropometric parameters (p<0.05). In conclusion, we report the development of a new fluorometric method that offers a reproducible and rapid means for determining HDL function/quality that is suitable for high throughput implementation.
    PLoS ONE 11/2014; 9(11):e111716. DOI:10.1371/journal.pone.0111716 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Persistent systemic inflammation, a typical feature of inflammatory rheumatic diseases, is associated with a high cardiovascular risk and predisposes to metabolic disorders and muscle wasting. These disorders can lead to disability and decreased physical activity, exacerbating inflammation and the development of a network of chronic diseases, thus establishing a 'vicious cycle' of chronic inflammation. During the past two decades, advances in research have shed light on the role of exercise as a therapy for rheumatic diseases. One of the most important of these advances is the discovery that skeletal muscle communicates with other organs by secreting proteins called myokines. Some myokines are thought to induce anti-inflammatory responses with each bout of exercise and mediate long-term exercise-induced improvements in cardiovascular risk factors, having an indirect anti-inflammatory effect. Therefore, contrary to fears that physical activity might aggravate inflammatory pathways, exercise is now believed to be a potential treatment for patients with rheumatic diseases. In this Review, we discuss how exercise disrupts the vicious cycle of chronic inflammation directly, after each bout of exercise, and indirectly, by improving comorbidities and cardiovascular risk factors. We also discuss the mechanisms by which some myokines have anti-inflammatory functions in inflammatory rheumatic diseases.
    Nature Reviews Rheumatology 11/2014; DOI:10.1038/nrrheum.2014.193 · 10.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die rheumatoide Arthritis (RA) und der systemische Lupus erythematodes (SLE) sind mit einer erhöhten Mortalität assoziiert, die hauptsächlich auf kardiovaskuläre Erkrankungen zurückzuführen ist. Das Risiko für einen Herzinfarkt ist bei RA-Betroffenen verdoppelt und bei SLE-Erkrankten sogar bis zu 7-fach erhöht.Neben den traditionellen Risikofaktoren hat eine chronische systemische Entzündung bedeutenden Einfluss auf die Entstehung der Arteriosklerose und die Progression von einer endothelialen Dysfunktion zur Plaqueruptur mit Thrombose. Zahlreiche Studien haben gezeigt, dass die Arteriosklerose keine alleinige, passive Lipidakkumulation in den Gefäßwänden darstellt, sondern durch einen aktiven Entzündungsprozess in den Gefäßwänden charakterisiert ist. Entzündungszellen wie Makrophagen, Monozyten und T-Zellen spielen sowohl bei der Entwicklung der RA als auch der Arteriosklerose eine entscheidende Rolle.Nach den Empfehlungen der EULAR sollen alle Patienten mit inflammatorischen Arthritiden ein jährliches Screening auf kardiovaskuläre Risikofaktoren erhalten. Alle Risikofaktoren sollten optimal eingestellt werden. Zudem gibt es genügend Evidenz, dass die entzündlichen systemischen und vaskulären Prozesse zur Reduktion des kardiovaskulären Risikos gleichzeitig reduziert werden sollten.
    Zeitschrift für Rheumatologie 01/2010; 69(8). DOI:10.1007/s00393-009-0585-5 · 0.46 Impact Factor

Full-text (2 Sources)

Available from
May 27, 2014